Entacapone
SIGMA/SML0654 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 130929-57-6
Empirical Formula (Hill Notation): C14H15N3O5
Molecular Weight: 305.29
Linear Formula: C14H15N3O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to light brown |
| form | powder |
| InChI | 1S/C14H15N3O5/c1-3-16(4-2 |
| InChI key | JRURYQJSLYLRLN-BJMVGYQFSA |
| Quality Level | 100 ![]() |
| SMILES string | [N+](=O)([O-])c1c(c(cc(c1 |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | room temp |
| Application: | Entacapone has been used in high-performance bioaffinity chromatography. |
| Biochem/physiol Actions: | Entacapone acts predominantly in the intestine. It increases the bioavailability of levodopa. Levodopa is known to be associated with many complications such as motor fluctuations. COMT inhibitors have been used to overcome these adverse effects of levodopa by reducing its metabolism. Entacapone exhibits its inhibition action on COMT in the peripheral nervous system. |
| Biochem/physiol Actions: | Entacapone is a catechol-O-methyl transferase (COMT) inhibitor. Antiparkinson; anti-Dyskinesia. |
| Biochem/physiol Actions: | Entacapone is a catechol-O-methyl transferase (COMT) inhibitor. Used in treatment of Parkinson′s disease, entacapone is administered with L-DOPA to inihibit COMT from converting L-DOPA into a compound that cannot cross the blood brain barrier. |
| Features and Benefits: | This compound is featured on the Dopamine and Norepinephrine Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |

